Prosecution Insights
Last updated: April 19, 2026

BEIJING TIDE PHARMACEUTICAL CO., LTD.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
0
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18023405 PREPARATION METHOD FOR NOVEL RHO-RELATED PROTEIN KINASE INHIBITOR AND INTERMEDIATE IN PREPARATION METHOD MCDOWELL, BRIAN E 1624 Non-Final OA Feb 27, 2023
17637690 COMPOUND INHIBITING AND INDUCING DEGRADATION OF EGFR AND ALK SHTERENGARTS, SAMANTHA L 1623 Non-Final OA Feb 23, 2022
17607438 METHOD FOR TREATING COUGH BY USING DIAMINOPYRIMIDINE COMPOUND PECKHAM, RICHARD GRANT 1627 Non-Final OA Oct 29, 2021
17367726 RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF HABTE, KAHSAY 1624 Non-Final OA Jul 06, 2021

Managing BEIJING TIDE PHARMACEUTICAL CO., LTD.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month